Cardiometabolic risks in PCOS

a review of the current state of knowledge

Research output: Contribution to journalReview ArticleResearchpeer-review

2 Citations (Scopus)

Abstract

Introduction: Polycystic ovary syndrome (PCOS) is a common endocrine disorder affecting up to 18% women of reproductive age. It is associated with a range of metabolic, reproductive, and psychological features. Current evidence indicates a role of PCOS in the development of metabolic and increased cardiovascular risk factors (CVRF) with implications for compromised cardiovascular endpoint disease, which may have a considerable impact on health and health care costs. Areas covered: Existing studies examining long-term cardiometabolic health in PCOS are heterogeneous with inconsistent findings. In the current review, we aim to explore and critically review retrospective, prospective, meta-analysis and review articles relating to PCOS on cardiometabolic risk factors and clinical consequences to summarize the evidence, note evidence gaps, and suggest implications for future research. Expert commentary: Although there is an established association between PCOS and metabolic health, implications on cardiac health are more uncertain with associations observed for CVRF and subclinical disease, yet limited and conflicting data on actual cardiovascular endpoints. There is a lack of population-based long-term studies examining cardiometabolic morbidity and mortality in PCOS with a need for further research to progress toward a better understanding of the long-term cardiometabolic impacts in women with PCOS.

Original languageEnglish
Pages (from-to)23-33
Number of pages11
JournalExpert Review of Endocrinology and Metabolism
Volume14
Issue number1
DOIs
Publication statusPublished - 2 Jan 2019

Keywords

  • Cardiovascular disease
  • insulin resistance
  • metabolic syndrome
  • obesity
  • polycystic ovary syndrome
  • type 2 diabetes

Cite this

@article{304bb494eb4a41eaa0e370e30e8e1622,
title = "Cardiometabolic risks in PCOS: a review of the current state of knowledge",
abstract = "Introduction: Polycystic ovary syndrome (PCOS) is a common endocrine disorder affecting up to 18{\%} women of reproductive age. It is associated with a range of metabolic, reproductive, and psychological features. Current evidence indicates a role of PCOS in the development of metabolic and increased cardiovascular risk factors (CVRF) with implications for compromised cardiovascular endpoint disease, which may have a considerable impact on health and health care costs. Areas covered: Existing studies examining long-term cardiometabolic health in PCOS are heterogeneous with inconsistent findings. In the current review, we aim to explore and critically review retrospective, prospective, meta-analysis and review articles relating to PCOS on cardiometabolic risk factors and clinical consequences to summarize the evidence, note evidence gaps, and suggest implications for future research. Expert commentary: Although there is an established association between PCOS and metabolic health, implications on cardiac health are more uncertain with associations observed for CVRF and subclinical disease, yet limited and conflicting data on actual cardiovascular endpoints. There is a lack of population-based long-term studies examining cardiometabolic morbidity and mortality in PCOS with a need for further research to progress toward a better understanding of the long-term cardiometabolic impacts in women with PCOS.",
keywords = "Cardiovascular disease, insulin resistance, metabolic syndrome, obesity, polycystic ovary syndrome, type 2 diabetes",
author = "Kakoly, {N. S.} and Moran, {L. J.} and Teede, {H. J.} and Joham, {A. E.}",
year = "2019",
month = "1",
day = "2",
doi = "10.1080/17446651.2019.1556094",
language = "English",
volume = "14",
pages = "23--33",
journal = "Expert Review of Endocrinology and Metabolism",
issn = "1744-6651",
publisher = "Taylor & Francis",
number = "1",

}

Cardiometabolic risks in PCOS : a review of the current state of knowledge. / Kakoly, N. S.; Moran, L. J.; Teede, H. J.; Joham, A. E.

In: Expert Review of Endocrinology and Metabolism, Vol. 14, No. 1, 02.01.2019, p. 23-33.

Research output: Contribution to journalReview ArticleResearchpeer-review

TY - JOUR

T1 - Cardiometabolic risks in PCOS

T2 - a review of the current state of knowledge

AU - Kakoly, N. S.

AU - Moran, L. J.

AU - Teede, H. J.

AU - Joham, A. E.

PY - 2019/1/2

Y1 - 2019/1/2

N2 - Introduction: Polycystic ovary syndrome (PCOS) is a common endocrine disorder affecting up to 18% women of reproductive age. It is associated with a range of metabolic, reproductive, and psychological features. Current evidence indicates a role of PCOS in the development of metabolic and increased cardiovascular risk factors (CVRF) with implications for compromised cardiovascular endpoint disease, which may have a considerable impact on health and health care costs. Areas covered: Existing studies examining long-term cardiometabolic health in PCOS are heterogeneous with inconsistent findings. In the current review, we aim to explore and critically review retrospective, prospective, meta-analysis and review articles relating to PCOS on cardiometabolic risk factors and clinical consequences to summarize the evidence, note evidence gaps, and suggest implications for future research. Expert commentary: Although there is an established association between PCOS and metabolic health, implications on cardiac health are more uncertain with associations observed for CVRF and subclinical disease, yet limited and conflicting data on actual cardiovascular endpoints. There is a lack of population-based long-term studies examining cardiometabolic morbidity and mortality in PCOS with a need for further research to progress toward a better understanding of the long-term cardiometabolic impacts in women with PCOS.

AB - Introduction: Polycystic ovary syndrome (PCOS) is a common endocrine disorder affecting up to 18% women of reproductive age. It is associated with a range of metabolic, reproductive, and psychological features. Current evidence indicates a role of PCOS in the development of metabolic and increased cardiovascular risk factors (CVRF) with implications for compromised cardiovascular endpoint disease, which may have a considerable impact on health and health care costs. Areas covered: Existing studies examining long-term cardiometabolic health in PCOS are heterogeneous with inconsistent findings. In the current review, we aim to explore and critically review retrospective, prospective, meta-analysis and review articles relating to PCOS on cardiometabolic risk factors and clinical consequences to summarize the evidence, note evidence gaps, and suggest implications for future research. Expert commentary: Although there is an established association between PCOS and metabolic health, implications on cardiac health are more uncertain with associations observed for CVRF and subclinical disease, yet limited and conflicting data on actual cardiovascular endpoints. There is a lack of population-based long-term studies examining cardiometabolic morbidity and mortality in PCOS with a need for further research to progress toward a better understanding of the long-term cardiometabolic impacts in women with PCOS.

KW - Cardiovascular disease

KW - insulin resistance

KW - metabolic syndrome

KW - obesity

KW - polycystic ovary syndrome

KW - type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=85059795049&partnerID=8YFLogxK

U2 - 10.1080/17446651.2019.1556094

DO - 10.1080/17446651.2019.1556094

M3 - Review Article

VL - 14

SP - 23

EP - 33

JO - Expert Review of Endocrinology and Metabolism

JF - Expert Review of Endocrinology and Metabolism

SN - 1744-6651

IS - 1

ER -